Epassi Group, a market leader for digital employee benefit payments in the Nordics, UK and Italy, today announced the strategic acquisition of Exercite, a provider of corporate health and wellness benefit solutions in Germany and the Netherlands, from Waterland Private Equity (“Waterland”) and its founders.
Reimagine Care, the nation’s leading provider of virtual and in-home cancer care, along with CU Innovations at the University of Colorado Anschutz Medical Campus (CU), a leading research institution committed to fostering innovation and excellence in education and healthcare, are proud to announce a poster presentation at the prestigious 2023 American Society of Hematology (ASH) Annual Meeting and Exposition.
Salus Optima, a leading provider in AI-enabled digital health and wellness solutions, and the Consumer Health division of Bayer have launched a strategic partnership to empower people on their healthy aging journey.
Fraser Health Authority, a large regional health authority, will be one of the first health systems globally to deploy generative AI to assist with clinical documentation in MEDITECH’s Expanse EHR, using Google Cloud’s Vertex AI and large language models (LLMs).
DexCom, Inc., the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects with the t:slim X2™ insulin pump by Tandem Diabetes Care in the United States, marking the first AID integration with the Dexcom G7 CGM, the world’s most accurate1,2 CGM system.
Zepp Health Corporation, a global leader in smart wearables and health technology, commemorates its 10th anniversary with a brand refresh.
The Biospectal OptiBP app is the first and only software-only blood pressure monitoring solution on smartphones to receive the CE Mark, democratizing worldwide access to easy, connected blood pressure management to combat hypertension, the world’s num...
DUOS, a digital health company empowering older adults to live independently and attain the highest level of health in partnership with health plans, today announced the launch of its latest initiative, Connections for a Cause.
Verato, the identity experts for healthcare, today announced that UofL Health, a fully integrated regional academic health system, will partner with Verato to deploy Verato’s healthcare master data management (hMDM) solution to support accurate identity management across UofL Health’s entire enterprise.
Eligo Bioscience, a pioneering gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, has announced a successful $30 million Series B funding round, led by Sanofi Ventures.